<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7546461\results\search\disease\results.xml">
  <result pre="Review : Medicine and Health Sciences : Medical Conditions :" exact="Infectious" post="Diseases : Viral Diseases: Covid 19 : Biology and"/>
  <result pre=": Medicine and Health Sciences : Medical Conditions : Infectious" exact="Diseases" post=": Viral Diseases: Covid 19 : Biology and life"/>
  <result pre="and Health Sciences : Medical Conditions : Infectious Diseases :" exact="Viral" post="Diseases: Covid 19 : Biology and life sciences :"/>
  <result pre="sciences : Microbiology : Medical microbiology : Microbial pathogens :" exact="Viral" post="pathogens : Coronaviruses : SARS coronavirus: SARS CoV 2"/>
  <result pre="Pathology and laboratory medicine : Pathogens : Microbial pathogens :" exact="Viral" post="pathogens : Coronaviruses : SARS coronavirus: SARS CoV 2"/>
  <result pre=": Biology and life sciences : Organisms : Viruses :" exact="Viral" post="pathogens : Coronaviruses : SARS coronavirus: SARS CoV 2"/>
  <result pre="2 : Medicine and Health Sciences : Medical Conditions :" exact="Infectious" post="Diseases: Respiratory Infections : Medicine and Health Sciences :"/>
  <result pre="Medicine and Health Sciences : Medical Conditions : Infectious Diseases:" exact="Respiratory" post="Infections : Medicine and Health Sciences : Medical Conditions"/>
  <result pre="and Health Sciences : Medical Conditions : Infectious Diseases: Respiratory" exact="Infections" post=": Medicine and Health Sciences : Medical Conditions :"/>
  <result pre="Infections : Medicine and Health Sciences : Medical Conditions :" exact="Respiratory" post="Disorders: Respiratory Infections : Medicine and Health Sciences :"/>
  <result pre="Medicine and Health Sciences : Medical Conditions : Respiratory Disorders:" exact="Respiratory" post="Infections : Medicine and Health Sciences : Pulmonology :"/>
  <result pre="and Health Sciences : Medical Conditions : Respiratory Disorders: Respiratory" exact="Infections" post=": Medicine and Health Sciences : Pulmonology : Respiratory"/>
  <result pre="Respiratory Infections : Medicine and Health Sciences : Pulmonology :" exact="Respiratory" post="Disorders: Respiratory Infections : Biology and Life Sciences :"/>
  <result pre=": Medicine and Health Sciences : Pulmonology : Respiratory Disorders:" exact="Respiratory" post="Infections : Biology and Life Sciences : Immunology :"/>
  <result pre="Medicine and Health Sciences : Pulmonology : Respiratory Disorders: Respiratory" exact="Infections" post=": Biology and Life Sciences : Immunology : Vaccination"/>
  <result pre="and Life Sciences : Genetics : Genomics : Microbial Genomics:" exact="Viral" post="Genomics : Biology and Life Sciences : Microbiology :"/>
  <result pre=": Biology and Life Sciences : Microbiology : Microbial Genomics:" exact="Viral" post="Genomics : Biology and Life Sciences : Microbiology :"/>
  <result pre="Genomics : Biology and Life Sciences : Microbiology : Virology:" exact="Viral" post="Genomics : Medicine and Health Sciences : Diagnostic Medicine:"/>
  <result pre="Odeke678http://orcid.org/0000-0002-9898-4997Ã�lvarez-RodrÃ­guezBeatriz5http://orcid.org/0000-0002-0005-9761MartÃ­-CarrerasJoan9[1], Laboratory of Experimental Virology, Department of Medical Microbiology and" exact="Infection" post="Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands[2],"/>
  <result pre="Biological Sciences, University of Leeds, Leeds, United Kingdom[6], Institute for" exact="Infectious" post="Diseases, University of Bern, Bern, Switzerland[7], Biology Division, Spiez"/>
  <result pre="credited.ppat.1008902.pdf Abstract The first cluster of patients suffering from coronavirus" exact="disease" post="2019 (COVID-19) was identified on December 21, 2019, and"/>
  <result pre="December 21, 2019, and as of July 29, 2020, severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have been linked"/>
  <result pre="21, 2019, and as of July 29, 2020, severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) infections have been linked with"/>
  <result pre="2019, and as of July 29, 2020, severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) infections have been linked with 664,333"/>
  <result pre="July 29, 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" exact="infections" post="have been linked with 664,333 deaths and number at"/>
  <result pre="COVID-19 pandemic has tested local, national, and international preparedness for" exact="viral" post="outbreaks to the limits. Just as it will be"/>
  <result pre="build on them. Concomitant to the emergence of a novel" exact="viral" post="disease, there is a â€˜research and development gapâ€™ that"/>
  <result pre="outline key components of an adequate research response to novel" exact="viral" post="outbreaks using the example of SARS-CoV-2. We highlight the"/>
  <result pre="science, resulting in the fastest scientific response to a major" exact="infectious disease" post="outbreak or pandemic. We underline the vital role of"/>
  <result pre="resulting in the fastest scientific response to a major infectious" exact="disease" post="outbreak or pandemic. We underline the vital role of"/>
  <result pre="population has tripled to 7.8 billion, with expansion in meat" exact="consumption" post="and living area thought to increase human exposure to"/>
  <result pre="with occasional â€˜spilloverâ€™ to people [1]. Approximately 60% of human" exact="infectious diseases" post="are zoonotic [2] (transmitted from animals). Zoonoses capable of"/>
  <result pre="Zoonoses capable of human-to-human transmission can emerge as catastrophic diseases;" exact="acquired immunodeficiency syndrome" post="(AIDS) alone has killed an estimated 32 million [3],"/>
  <result pre="capable of human-to-human transmission can emerge as catastrophic diseases; acquired" exact="immunodeficiency" post="syndrome (AIDS) alone has killed an estimated 32 million"/>
  <result pre="of human-to-human transmission can emerge as catastrophic diseases; acquired immunodeficiency" exact="syndrome" post="(AIDS) alone has killed an estimated 32 million [3],"/>
  <result pre="alone has killed an estimated 32 million [3], whilst coronavirus" exact="disease" post="2019 (COVID-19) has caused the largest global economic crisis"/>
  <result pre="has caused the largest global economic crisis since the Great" exact="Depression" post="[4]. Speed of response is critical with respect to"/>
  <result pre="Speed of response is critical with respect to mitigation of" exact="infectious" post="outbreaks, since in a susceptible population, the number of"/>
  <result pre="infectious outbreaks, since in a susceptible population, the number of" exact="infections" post="may increase exponentially. The aim of outbreak preparedness is"/>
  <result pre="whilst case numbers are low. For well-established diseases such as" exact="measles" post="in humans, this preparation includes systems for (1) detection"/>
  <result pre="outbreak. Fig 1 Key components of the research response to" exact="viral" post="outbreaks are shown as a simplified workflow. Factors complicating"/>
  <result pre="discovery of SARS-CoV-2 When unusually high incidence of a clinical" exact="syndrome" post="is observed in a group of patients (a cluster),"/>
  <result pre="which investigations were carried out by the Chinese Center for" exact="Disease" post="Control and Prevention and the National Institute of Viral"/>
  <result pre="for Disease Control and Prevention and the National Institute of" exact="Viral" post="Disease Control and Prevention [7,8]. A diagnostic panel covering"/>
  <result pre="Disease Control and Prevention and the National Institute of Viral" exact="Disease" post="Control and Prevention [7,8]. A diagnostic panel covering 22"/>
  <result pre="from the initial COVID-19 cluster and published in a remarkably" exact="short" post="34 days [8] (Fig 2). Virus was grown in"/>
  <result pre="short 34 days [8] (Fig 2). Virus was grown in" exact="primary" post="human airway epithelial cell cultures, which provide optimal substrates"/>
  <result pre="[8] (Fig 2). Virus was grown in primary human airway" exact="epithelial" post="cell cultures, which provide optimal substrates for coronavirus replication"/>
  <result pre="and surface spikes characteristic of coronaviruses [8]. The first severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes were published online"/>
  <result pre="surface spikes characteristic of coronaviruses [8]. The first severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) genomes were published online on"/>
  <result pre="spikes characteristic of coronaviruses [8]. The first severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) genomes were published online on January"/>
  <result pre="analyses showed the virus was a relative of both severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV-1) [7] (i.e., the etiological agent"/>
  <result pre="showed the virus was a relative of both severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV-1) [7] (i.e., the etiological agent of"/>
  <result pre="the virus was a relative of both severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV-1) [7] (i.e., the etiological agent of the"/>
  <result pre="research response: contrasting the SARS-CoV-1 and SARS-CoV-2 outbreaks. COVID-19, coronavirus" exact="disease" post="2019; PCR, polymerase chain reaction; PHEIC, Public Health Emergency"/>
  <result pre="reaction; PHEIC, Public Health Emergency of International Concern; SARS-CoV-1, severe" exact="acute" post="respiratory syndrome coronavirus; SARS-CoV-2, severe acute respiratory syndrome coronavirus"/>
  <result pre="PHEIC, Public Health Emergency of International Concern; SARS-CoV-1, severe acute" exact="respiratory" post="syndrome coronavirus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2;"/>
  <result pre="Public Health Emergency of International Concern; SARS-CoV-1, severe acute respiratory" exact="syndrome" post="coronavirus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO,"/>
  <result pre="International Concern; SARS-CoV-1, severe acute respiratory syndrome coronavirus; SARS-CoV-2, severe" exact="acute" post="respiratory syndrome coronavirus 2; WHO, World Health Organization. Testing,"/>
  <result pre="Concern; SARS-CoV-1, severe acute respiratory syndrome coronavirus; SARS-CoV-2, severe acute" exact="respiratory" post="syndrome coronavirus 2; WHO, World Health Organization. Testing, tracing,"/>
  <result pre="SARS-CoV-1, severe acute respiratory syndrome coronavirus; SARS-CoV-2, severe acute respiratory" exact="syndrome" post="coronavirus 2; WHO, World Health Organization. Testing, tracing, and"/>
  <result pre="COVID-19 patients are separated from SARS-CoV-2 negative individuals and confirms" exact="viral" post="shedding has ceased before discharge. Testing in the community"/>
  <result pre="shedding has ceased before discharge. Testing in the community uncovers" exact="viral" post="transmission dynamics to support control policies, such as prevalence"/>
  <result pre="prevalence in vulnerable demographics [12], case fatality [13], or the" exact="viral" post="basic reproduction number [14] (i.e., R0, the average number"/>
  <result pre="reproduction number [14] (i.e., R0, the average number of further" exact="infections" post="arising from 1 case in a naÃ¯ve population). The"/>
  <result pre="isothermal amplification (LAMP) assays, which can rapidly and sensitively detect" exact="viral" post="RNA or cDNA with minimal equipment, were also validated"/>
  <result pre="samples only 2 months after the outbreak emerged [16â€&quot;18]. Tracing" exact="viral" post="spread by identifying infected individuals and their potential contacts"/>
  <result pre="2), nearly 5 months into the SARS-CoV-2 pandemic, over 27,000" exact="complete" post="genomes could be downloaded from the GISAID sequence repository"/>
  <result pre="new variants. Utilising the genome: Fundamental research and development A" exact="viral" post="genome sequence is a launchpad for a range of"/>
  <result pre="which are used to safely produce pure stocks of individual" exact="viral" post="proteins. The gene sequence is first amplified from a"/>
  <result pre="gene sequence is first amplified from a clinical sample or" exact="viral" post="culture using PCR or is synthetically constructed. The DNA"/>
  <result pre="cells, which produce (express) the protein encoded by the gene." exact="Viral" post="proteins are used in the generation of traditional antibody-based"/>
  <result pre="as enzyme-linked immunosorbent assays (ELISAs), which are designed to detect" exact="viral" post="proteins in patient samples or patient antibodies against the"/>
  <result pre="the gold standard for laboratory diagnosis of an active SARS-CoV-2" exact="infection" post="[28], serological assays can detect historical infections and play"/>
  <result pre="an active SARS-CoV-2 infection [28], serological assays can detect historical" exact="infections" post="and play a key role in determining population attack"/>
  <result pre="flow assays (LFAs) are used as rapid tests for prior" exact="viral" post="exposure and were first reported 2 months after cluster"/>
  <result pre="the binding of some anti-SARS-CoV-1 antibodies. This was followed in" exact="short" post="order by structures including the cellular receptor ACE2 [35]"/>
  <result pre="SARS-CoV-2 proteins in human cells, followed by separation of the" exact="viral" post="proteins (and bound host proteins) from the host background."/>
  <result pre="animals are necessary to establish their potential role in forming" exact="viral" post="reservoirs and to provide data that are informative on"/>
  <result pre="and other therapeutics for use in humans [42,43]. Establishment of" exact="viral" post="cultures is vital for numerous downstream applications, including generating"/>
  <result pre="vital for numerous downstream applications, including generating these in vivo" exact="infection" post="models for therapeutic testing [44], antiviral screening [45], and"/>
  <result pre="genome sequence is requiredâ€&quot;synthetic DNA technology allows the reconstruction of" exact="viral" post="genomes in artificial vectorsâ€&quot;from which viable infectious RNA can"/>
  <result pre="the reconstruction of viral genomes in artificial vectorsâ€&quot;from which viable" exact="infectious" post="RNA can be produced and replicating virus rescued. The"/>
  <result pre="genetic engineering to study genotype-to-phenotype relationships and the function of" exact="viral" post="components, and also enables validation of diagnostic tests in"/>
  <result pre="components, and also enables validation of diagnostic tests in the" exact="absence of" post="clinical specimens [15]. Delivering pharmaceutical interventions to the clinic"/>
  <result pre="approved drugs can have major consequences in outbreak situations, causing" exact="acute" post="shortages and rendering them unavailable to patients using them"/>
  <result pre="outbreak. Delivery of neutralising antibodies (nAbs) to patients early in" exact="disease" post="is another treatment option. Serum from convalescent COVID-19 patients"/>
  <result pre="in May by a humanised antibody (47D11) capable of blocking" exact="infection" post="with both SARS-CoV-1 and SARS-CoV-2 in vitro [62]. Also"/>
  <result pre="implying suitability as a cocktail therapy with reduced risk of" exact="viral" post="escape. Vaccines are used to safely increase immunity levels"/>
  <result pre="populations in order to protect individuals and reduce pathways to" exact="viral" post="spread. For SARS-CoV-2, a remarkably fast and broad vaccine"/>
  <result pre="mRNA vaccination [65], which requires relatively little development time after" exact="viral" post="genome sequencing. If successfully tested and deployed, these novel"/>
  <result pre="data utility is achieved by prompt release. The pace of" exact="viral" post="genome publication during crises was highlighted as a problem"/>
  <result pre="July 29, 2020. The cost of this speed is the" exact="absence of" post="peer review, which can sometimes result in the publication"/>
  <result pre="a necessary quality standard. Encouragingly, this openness has not been" exact="limited" post="to academic spheres; many major technology companies including Intel,"/>
  <result pre="treatments [82], which involves over 100 countries and intends to" exact="complete" post="80% faster than a typical randomised clinical trial. Representative"/>
  <result pre="where research resources, laboratory facilities, and manufacturing infrastructures are commonly" exact="limited" post="relative to high-income countries [84]. 10.1371/journal.ppat.1008902.t001Table 1 A selection"/>
  <result pre="Real-time molecular epidemiology for outbreak response https://artic.network/ CEPI Coalition for" exact="Epidemic" post="Preparedness Innovations https://cepi.net/ COMPARE COllaborative Management Platform for detection"/>
  <result pre="outbreaks in Europe https://www.compare-europe.eu/ COPCOV Chloroquine/ hydroxychloroquine prevention of Coronavirus" exact="Disease" post="(COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis"/>
  <result pre="Clinical Research Coalition https://covid19crc.org/ ECRAID European Clinical Research Alliance on" exact="Infectious" post="Diseases https://www.ecraid.eu/ eMERGE Electronic Medical Records and Genomics https://emerge-network.org/"/>
  <result pre="Research Coalition https://covid19crc.org/ ECRAID European Clinical Research Alliance on Infectious" exact="Diseases" post="https://www.ecraid.eu/ eMERGE Electronic Medical Records and Genomics https://emerge-network.org/ GLOPID-R"/>
  <result pre="Medical Records and Genomics https://emerge-network.org/ GLOPID-R Global Research Collaboration for" exact="Infectious" post="Disease Preparedness https://www.glopid-r.org/ HONOURs Host switching pathogens, infectious outbreaks,"/>
  <result pre="Records and Genomics https://emerge-network.org/ GLOPID-R Global Research Collaboration for Infectious" exact="Disease" post="Preparedness https://www.glopid-r.org/ HONOURs Host switching pathogens, infectious outbreaks, and"/>
  <result pre="Collaboration for Infectious Disease Preparedness https://www.glopid-r.org/ HONOURs Host switching pathogens," exact="infectious" post="outbreaks, and zoonosis https://www.honours.eu/ IDCRC Infectious Diseases Clinical Research"/>
  <result pre="HONOURs Host switching pathogens, infectious outbreaks, and zoonosis https://www.honours.eu/ IDCRC" exact="Infectious" post="Diseases Clinical Research Consortium https://med.emory.edu/departments/medicine/divisions/infectious-diseases/idcrc/index.htm INITIATE Innate-Immunometablism as Antiviral"/>
  <result pre="Host switching pathogens, infectious outbreaks, and zoonosis https://www.honours.eu/ IDCRC Infectious" exact="Diseases" post="Clinical Research Consortium https://med.emory.edu/departments/medicine/divisions/infectious-diseases/idcrc/index.htm INITIATE Innate-Immunometablism as Antiviral Target"/>
  <result pre="Consortium https://med.emory.edu/departments/medicine/divisions/infectious-diseases/idcrc/index.htm INITIATE Innate-Immunometablism as Antiviral Target https://initiate-itn.eu/ ISARIC International" exact="Severe" post="Acute Respiratory and emerging Infection Consortium https://isaric.tghn.org/ PANDORA Pan-African"/>
  <result pre="https://med.emory.edu/departments/medicine/divisions/infectious-diseases/idcrc/index.htm INITIATE Innate-Immunometablism as Antiviral Target https://initiate-itn.eu/ ISARIC International Severe" exact="Acute" post="Respiratory and emerging Infection Consortium https://isaric.tghn.org/ PANDORA Pan-African Network"/>
  <result pre="INITIATE Innate-Immunometablism as Antiviral Target https://initiate-itn.eu/ ISARIC International Severe Acute" exact="Respiratory" post="and emerging Infection Consortium https://isaric.tghn.org/ PANDORA Pan-African Network For"/>
  <result pre="Antiviral Target https://initiate-itn.eu/ ISARIC International Severe Acute Respiratory and emerging" exact="Infection" post="Consortium https://isaric.tghn.org/ PANDORA Pan-African Network For Rapid Research, Response"/>
  <result pre="PANDORA Pan-African Network For Rapid Research, Response and Preparedness for" exact="Infectious" post="Diseases Epidemics https://pandora.tghn.org/ PREPARE Platform for European Preparedness Against"/>
  <result pre="Pan-African Network For Rapid Research, Response and Preparedness for Infectious" exact="Diseases" post="Epidemics https://pandora.tghn.org/ PREPARE Platform for European Preparedness Against (Re-)emerging"/>
  <result pre="treatment for COVID-19, launched by WHO and partners https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments VIRUS-X" exact="Viral" post="metagenomics for innovation value http://virus-x.eu/ ZAPI Zoonotic Anticipation and"/>
  <result pre="ACTIV, Accelerating COVID-19 Therapeutic Interventions and Vaccines; CEPI, Coalition for" exact="Epidemic" post="Preparedness Innovations; COMPARE, COllaborative Management Platform for detection and"/>
  <result pre="foodborne outbreaks in Europe; COPCOV, Chloroquine/ hydroxychloroquine prevention of Coronavirus" exact="Disease" post="(COVID-19) in the healthcare setting; COVID-19, coronavirus disease 2019;"/>
  <result pre="of Coronavirus Disease (COVID-19) in the healthcare setting; COVID-19, coronavirus" exact="disease" post="2019; COVID-19 CRC, COVID-19 Clinical Research Coalition; COV-IRT, COVID-19"/>
  <result pre="COVID-19 International Research Team; ECRAID, European Clinical Research Alliance on" exact="Infectious" post="Diseases; eMERGE, Electronic Medical Records and Genomics; GLOPID-R, Global"/>
  <result pre="Electronic Medical Records and Genomics; GLOPID-R, Global Research Collaboration for" exact="Infectious" post="Disease Preparedness; IDCRC, Infectious Diseases Clinical Research Consortium; INITIATE,"/>
  <result pre="Medical Records and Genomics; GLOPID-R, Global Research Collaboration for Infectious" exact="Disease" post="Preparedness; IDCRC, Infectious Diseases Clinical Research Consortium; INITIATE, Innate-Immunometablism"/>
  <result pre="Genomics; GLOPID-R, Global Research Collaboration for Infectious Disease Preparedness; IDCRC," exact="Infectious" post="Diseases Clinical Research Consortium; INITIATE, Innate-Immunometablism as Antiviral Target;"/>
  <result pre="GLOPID-R, Global Research Collaboration for Infectious Disease Preparedness; IDCRC, Infectious" exact="Diseases" post="Clinical Research Consortium; INITIATE, Innate-Immunometablism as Antiviral Target; ISARIC,"/>
  <result pre="Clinical Research Consortium; INITIATE, Innate-Immunometablism as Antiviral Target; ISARIC, International" exact="Severe" post="Acute Respiratory and emerging Infection Consortium; PANDORA, Pan-African Network"/>
  <result pre="Research Consortium; INITIATE, Innate-Immunometablism as Antiviral Target; ISARIC, International Severe" exact="Acute" post="Respiratory and emerging Infection Consortium; PANDORA, Pan-African Network For"/>
  <result pre="Consortium; INITIATE, Innate-Immunometablism as Antiviral Target; ISARIC, International Severe Acute" exact="Respiratory" post="and emerging Infection Consortium; PANDORA, Pan-African Network For Rapid"/>
  <result pre="as Antiviral Target; ISARIC, International Severe Acute Respiratory and emerging" exact="Infection" post="Consortium; PANDORA, Pan-African Network For Rapid Research, Response and"/>
  <result pre="PANDORA, Pan-African Network For Rapid Research, Response and Preparedness for" exact="Infectious" post="Diseases Epidemics; PREPARE, Platform for European Preparedness Against (Re-)emerging"/>
  <result pre="Pan-African Network For Rapid Research, Response and Preparedness for Infectious" exact="Diseases" post="Epidemics; PREPARE, Platform for European Preparedness Against (Re-)emerging Epidemics;"/>
  <result pre="Epidemics; RECOVER, Rapid European COVID-19 Emergency Response research; SARS-CoV-2, severe" exact="acute" post="respiratory syndrome coronavirus 2; WHO, World Health Organization; ZAPI,"/>
  <result pre="RECOVER, Rapid European COVID-19 Emergency Response research; SARS-CoV-2, severe acute" exact="respiratory" post="syndrome coronavirus 2; WHO, World Health Organization; ZAPI, Zoonotic"/>
  <result pre="Rapid European COVID-19 Emergency Response research; SARS-CoV-2, severe acute respiratory" exact="syndrome" post="coronavirus 2; WHO, World Health Organization; ZAPI, Zoonotic Anticipation"/>
  <result pre="outbreaks is at an all-time high. The massive threat that" exact="viral" post="outbreaks pose to lives and economies underscores the need"/>
  <result pre="Microbiol. 2017;15:502â€&quot;510. 10.1038/nrmicro.2017.4528555073 2TaylorLH, LathamSM, WoolhouseMEJ. Risk factors for human" exact="disease" post="emergence.Philos Trans R Soc B Biol Sci. 2001;356:983â€&quot;989. 3Joint"/>
  <result pre="5World Health Organization. Guidelines for epidemic preparedness and response to" exact="measles" post="outbreaks. Geneva; 1999. 6World Health Organization. R&amp;amp;D Blueprint. 2016."/>
  <result pre="field: a novel coronavirus genome identified in a cluster of" exact="pneumonia" post="casesâ€&quot;Wuhan, China 2019âˆ’2020.China CDC Wkly.2020;2:61â€&quot;62. 8ZhuN, ZhangD, WangW, LiX,"/>
  <result pre="LiX, YangB, SongJ, et al.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019.N Engl J Med. 2020;382:727â€&quot;733. 10.1056/NEJMoa200101731978945 9PyrcK,"/>
  <result pre="infects, replicates, and produces progeny virions in human ciliated airway" exact="epithelial" post="cell cultures. J Virol. 2010;84:11255â€&quot;11263. 10.1128/JVI.00947-1020719951 10JonsdottirHR, DijkmanR. Coronaviruses"/>
  <result pre="J.2016;13:1â€&quot;9. 10.1186/s12985-015-0456-426728778 11ZhouP, YangX, LouWXG, HuB, ZhangL, ZhangW, et al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="Nature. 2020;579:270â€&quot;273. 10.1038/s41586-020-2012-732015507 12BaggettTP, KeyesH, SpornN, GaetaJM. Prevalence of SARS-CoV-2" exact="infection" post="in residents of a large homeless shelter in Boston."/>
  <result pre="WinskillP, WhittakerC, ImaiN, et al.Estimates of the severity of coronavirus" exact="disease" post="2019: a model-based analysis.Lancet Infect Dis. 2020. 14LiQ, GuanX,"/>
  <result pre="application of a rapid IgM-IgG combined antibody test for SARS-CoV-2" exact="infection" post="diagnosis. J Med Virol. 2020:1â€&quot;7. 32BroughtonJP, DengX, YuG, FaschingCL,"/>
  <result pre="inhibitor. Cell. 2020;181:271â€&quot;280.e8. 10.1016/j.cell.2020.02.05232142651 36YanR, ZhangY, LiY, XiaL, GuoY, ZhouQ." exact="Structural" post="basis for the recognition of SARS-CoV-2 by full-length human"/>
  <result pre="LiR, VergoteV, SeldeslachtsL, et al.STAT2 signaling as double-edged sword restricting" exact="viral" post="dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters.bioRxiv.2020."/>
  <result pre="signaling as double-edged sword restricting viral dissemination but driving severe" exact="pneumonia" post="in SARS-CoV-2 infected hamsters.bioRxiv.2020. 45WestonS, HauptR, LogueJ, MatthewsK, FriemanM."/>
  <result pre="to treat COVID-19 causes fears of shortages among people with" exact="systemic" post="lupus erythematosus. Nat Med. 2020;26:632. 49U.S. Food &amp;amp; Drug"/>
  <result pre="treat COVID-19 causes fears of shortages among people with systemic" exact="lupus erythematosus." post="Nat Med. 2020;26:632. 49U.S. Food &amp;amp; Drug Administration. FDA"/>
  <result pre="et al.Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from" exact="disease" post="in a small animal model. Science. 2020:eabc7520. 64BrouwerPJM, CanielsTG,"/>
  <result pre="Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2" exact="Infection" post="(COVID-19). Available from: https://clinicaltrials.gov/ct2/show/NCT04283461. 66OrellanaC, PhaseI. SARS vaccine trial"/>
  <result pre="research open access. Nature2015;518:477â€&quot;479. Available from: https://www.nature.com/news/data-sharing-make-outbreak-research-open-access-1.16966. 10.1038/518477a25719649 70Centers for" exact="Disease" post="Control and Prevention. COVID-19 Databases and Journals. Available from:"/>
  <result pre="VerschoorE, BeerM, HÃ¶perD, WernikeK, Van RanstM, et al.Host switching pathogens," exact="infectious" post="outbreaks and zoonosis: a Marie SkÅ‚odowska-Curie innovative training network"/>
 </snippets>
</snippetsTree>
